6 completed, 1 recruiting, 1 terminated, 1 withdrawn. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Completed 6, Recruiting 1, Terminated 1, Withdrawn 1 |
Follow Hypercalcemia: new trials by email Literature Review of Hypercalcemia trials Research Report on Hypercalcemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity Calcitonin - Primary Hyperparathyroidism, Hypercalcemia | Phase 4 | Recruiting | Joseph Sferra | 37 | 2019-05-29 | 2024-09-19 |
| Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol Calcitriol, Paricalcitol - Kidney Failure, Secondary Hyperparathyroidism | Phase 4 | Terminated | Winthrop University Hospital | 16 | 2012-11-01 | 2023-11-07 |
| Parathyroidectomy vs Cinacalcet in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation Subtotal parathyroidectomy, Cinacalcet - Secondary Hyperparathyroidism | Phase 4 | Completed | Josep M Cruzado | 30 | 2010-01-01 | 2015-04-28 |
| Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose Zemplar (paricalcitol) - Secondary Hyperparathyroidism, Renal Insufficiency, Chronic | Phase 4 | Completed | Abbott | 100 | 2009-05-01 | 2011-10-31 |
| Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT) Paricalcitol, Calcitriol - Secondary Hyperparathyroidism, Chronic Kidney Disease | Phase 4 | Completed | Washington University School of Medicine | 110 | 2009-02-01 | 2014-08-07 |
| Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism cinacalcet, Alendronate - Hyperparathyroidism, Primary, Osteoporosis | Phase 4 | Completed | Istituto Auxologico Italiano | 22 | 2008-05-01 | 2015-04-15 |
| The Effects of Alendronate After Cure of Primary Hyperparathyroidism Alendronate 70mg weekly - Hyperparathyroidism | Phase 4 | Withdrawn | Columbia University | 2006-07-01 | 2011-11-16 | |
| Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism paricalcitol - Secondary Hyperparathyroidism | Phase 4 | Completed | Papageorgiou General Hospital | 2005-02-01 | 2006-03-28 | |
| Does Treatment of Hypovitaminosis D Increase Calcium Absorption? Vitamin D - Osteoporosis, Osteopenia | Phase 4 | Completed | University of Wisconsin, Madison | 19 | 2005-01-01 | 2023-07-24 |
Hyperparathyroidism, Secondary (5) · Hyperparathyroidism, Primary (3) · Osteoporosis (3) · Hyperphosphatemia (2) · Renal Insufficiency, Chronic (2) · Bone Diseases, Metabolic (1) · Fractures, Bone (1) · Hypercalciuria (1) · Hyperparathyroidism (1) · Hypoparathyroidism (1) · Renal Insufficiency (1) · Vitamin D Deficiency (1)
Calcium Metabolism Disorders (9) · Endocrine System Diseases (9) · Metabolic Diseases (9) · Nutritional and Metabolic Diseases (9) · Parathyroid Diseases (9) · Water-Electrolyte Imbalance (9) · Hyperparathyroidism (7) · Bone Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Musculoskeletal Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Urogenital Diseases (3)
paricalcitol (4) · Alendronate (2) · Calcitriol (2) · Cinacalcet (2) · Calcitonin (1) · Ergocalciferols (1) · Parathyroidectomy (1) · Vitamin D (1) · salmon calcitonin (1)
Abbott (1) · Columbia University (1) · Istituto Auxologico Italiano (1) · Josep M Cruzado (1) · Joseph Sferra (1) · Papageorgiou General Hospital (1) · University of Wisconsin, Madison (1) · Washington University School of Medicine (1) · Winthrop University Hospital (1)
United States (5) · Italy (1) · Peru (1) · Spain (1)
Daniel W Coyne, MD (1) · Efstathios Mitsopoulos, MD (1) · Josep M Cruzado, MD (1) · Joseph Sferra, MD (1) · Karen E Hansen, MD (1) · Oscar E Guerra, MD (1) · Pablo Moreno, MD (1) · Shayan Shirazian, MD (1) · Shonni J. Silverberg, MD (1)
2008 (1)